The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
News from our Partners at INSERM
Congratulations to Dr Florent Petitprez who earned his PhD. Florent's PhD project was titled: Analyse intégrée et impact clinique des microenvironnements immunitaires et stromaux des tumeurs solides*. COLOSSUS is acknowledged in the PhD thesis. The research was [...]
COLOSSUS Winter 2019 newsletter is available
Read the latest project news in our Winter 2019 COLOSSUS newsletter. Get an update on the COLOSSUS translational trial and read the dissemination highlights too. In this edition, our 'Partner in the Spotlight" is Cancer Trials [...]
Colorectal Cancer- How is research in Ireland addressing the challenges?
On the island of Ireland, what research is ongoing to help advance treatments for colorectal cancer? To celebrate Colon Cancer Awareness month, COLOSSUS will be hosting and managing a public event on 30 April 2019 [...]